GuiLin Peng

13PUBLICATIONS
43CO-AUTHORS
Medical biotechnology diagnostics (incl. biosensors)Predictive and prognostic markersLiquid biopsiesMolecular targetsMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Dec 05, 2025
Personalized and Tumor Informed Circulating Tumor DNA Assay for Molecular Residual Disease Monitoring of Solid Malignancies.

Liping Liu, WenHua Liang, WuQiang Cao

|Jun 08, 2025
Chinese Expert Consensus on Leptomeningeal Metastases of Lung Cancer.

Gen Lin, Yongsheng Wang, Tao Xin

|Mar 24, 2025
"Dr. Jekyll and Mr. Hyde": AT2 Cells in Lung Regeneration and Tumor Development.

Xinyuan Tong, Gen Lin, Hongbin Ji

|Aug 07, 2024
Pretreatment pulmonary tumor necrosis is a promising prognostic imaging biomarker for first-line anti-PD-1/PD-L1 therapy in advanced lung squamous cell carcinoma: a multi-institutional, propensity score-matching cohort analysis.

Qiaofeng Zhong, Longfeng Zhang, Lin Wu

|May 30, 2024
Poor efficacy of immune checkpoint inhibitor treatment in advanced thymic carcinoma patients with liver metastases.

Yue Hao, Manyi Xu, Xiaohong Zeng

|Mar 11, 2024
A novel approach to evaluation of tumor response for advanced pulmonary adenocarcinoma using the intertumoral heterogeneity response score.

Xinlong Zheng, Tao Lu, Shiwen Wu

Pageof 3

Frequent Collaborators

6 joint publications

Chunwei Xu

6 joint publications

Wenxian Wang

6 joint publications

Zhengbo Song

6 joint publications

Yongchang Zhang